Adverse drug reaction monitoring and reporting at H.S.K hospital | 44081
Journal of Pharmaceutical Care & Health Systems

Journal of Pharmaceutical Care & Health Systems
Open Access

ISSN: 2376-0419

+44 1300 500008

Adverse drug reaction monitoring and reporting at H.S.K hospital and Research Center-Bagalkot

11th World Congress on Pharmaceutical sciences

September 28-29, 2018 | Montreal, Canada

Hemanth Kumar Nambari


Posters & Accepted Abstracts: J Pharma Care Health Sys

Abstract :

Introduction: Adverse drug reactions (ADRs) reporting is provides safety and Improves strength of drug adverse reaction to the Drug. Such ADR reporting programs encourage surveillance for ADRs, promote the reporting of ADRs and stimulate the education of health professionals regarding potential ADRs. Objective: ADR monitoring is an important part of post marketing surveillance which helps in generating data on safety of medications. Main Aim to ADRs Monitoring is to the Promoting rational use of drugs, Safe use of Medicine, Improving patient care, Improving public health. Methods and Material: This was a prospective, observational, voluntary reporting study. Study was conducted in H.S.K Hospital and Research centre, Navanagar, Bagalkot, Karnataka. Samples was collected from Skinand VD, General Medicine, Pediatric Department and in all age groups. We are taken support of WHO Scale, Naranjo scale, Hartwig scale, CDSCO Form to collect the data. Result: In our study observed 77 ADRs in overall 59 patients of with ADRs reported from 180 patients was reported from both inpatients and outpatients, in this outpatients were less compared to inpatient. Highest ADRs are reported in (28.4%) skin rashes, General Medicine (69.7%) in different organs like Hematology, Cardiology, and Central nerves system, Hepatic, Renal, Endocrine, Respiratory and Gastrointestinal. In those study Antibiotic (20.8%) were causes high ADRs in those moderate level (75.3%) ADRs high than sever (10.4) in those as per WHO scale casual assessment probable (46.8%) ADRs were high. As per age group Incidence of ADRs among 0-15 age is 1.7% is less than 16-30 age group is 32.2% and is significantly higher than other age groups. In these studies we got type-A reactions as 26.08% is less than type-B reactions as 73.92%. Conclusion: The present evaluation has revealed opportunities for interventions especially for the avoidable ADRs which will help in promoting safer drug use, information to the healthcare professionals. Improve the quality of patient care and educate to increase awareness.

Biography :